Corrigendum: HIV-1 Env associates with HLA-C free-chains at the cell membrane modulating viral infectivity (Scientific Reports DOI: 10.1038/srep40037);HIV-1 Env associates with HLA-C free-chains at the cell membrane modulating viral infectivity

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Serena, Michela ^a   Parolini, Francesca ^a   Biswas, Priscilla ^b   Sironi, Francesca ^b   Blanco Miranda, Almudena ^a   Zoratti, Elisa ^c   Scupoli, Maria Teresa ^c   Ziglio, Serena ^a,d   Valenzuela Fernandez, Agustin ^d   Gibellini, Davide ^a   Romanelli, Maria Grazia ^a   Siccardi, Antonio ^b   Malnati, Mauro ^b   Beretta, Alberto ^b   Zipeto, Donato ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c Laboratory of Translational Surgery   (Italy)

^d UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; HLA C ANTIGEN; PROTEIN BINDING; VIRUS ENVELOPE PROTEIN;

CELL MEMBRANE; GROWTH, DEVELOPMENT AND AGING; HEK293 CELL LINE; HELA CELL LINE; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; VIROLOGY;

BETA 2-MICROGLOBULIN; CELL MEMBRANE; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HEK293 CELLS; HELA CELLS; HIV INFECTIONS; HIV-1; HLA-C ANTIGENS; HOST-PATHOGEN INTERACTIONS; HUMANS; PROTEIN BINDING;

EID: 85008419301     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep46991     Document Type: Erratum

References (60)

1. Lakhashe, S. K., Thakar, M. R., Bharucha, K. E. & Paranjape, R. S. Quantitation of HLA proteins incorporated by human immunodeficiency virus type 1 and assessment of neutralizing activity of anti-HLA antibodies. J Virol 82, 428-434 (2008).
2. Esser, M. T. et al. Differential incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and major histocompatibility complex class I and II molecules into human immunodeficiency virus type 1 virions and microvesicles: implications for viral pathogenesis and immune regulation. J Virol 75, 6173-6182 (2001).
3. Cosma, A. et al. Enhanced HIV infectivity and changes in GP120 conformation associated with viral incorporation of human leucocyte antigen class I molecules. Aids 13, 2033-2042 (1999).
4. Matucci, A. et al. HLA-C increases HIV-1 infectivity and is associated with gp120. Retrovirology 5, 68 (2008).
5. Baroni, M. et al. HLA-C is necessary for optimal human immunodeficiency virus type 1 infection of human peripheral blood CD4 lymphocytes. The Journal of general virology 91, 235-241 (2010).
6. Thomas, R. et al. HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat Genet 41, 1290-1294 (2009).
7. Kulkarni, S. et al. Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature 472, 495-498 (2011).
8. McMichael, A. J. & Jones, E. Y. Genetics. First-class control of HIV-1. Science 330, 1488-1490 (2010).
9. Matano, T. et al. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J Virol 72, 164-169 (1998).
10. Apps, R. et al. HIV-1 Vpu Mediates HLA-C Downregulation. Cell Host Microbe 19, 686-695 (2016).
11. Bettens, F., Brunet, L. & Tiercy, J. M. High-allelic variability in HLA-C mRNA expression: association with HLA-extended haplotypes. Genes Immun 15, 176-181 (2014).
12. Groothuis, T. A., Griekspoor, A. C., Neijssen, J. J., Herberts, C. A. & Neefjes, J. J. MHC class I alleles and their exploration of the antigen-processing machinery. Immunol Rev 207, 60-76 (2005).
13. Mccutcheon, J. A., Gumperz, J., Smith, K. D., Lutz, C. T. & Parham, P. Low Hla-C Expression at Cell-Surfaces Correlates with Increased Turnover of Heavy-Chain Messenger-Rna. Journal of Experimental Medicine 181, 2085-2095 (1995).
14. Zipeto, D. & Beretta, A. HLA-C and HIV-1: Friends or Foes? Retrovirology 9, 39 (2012).
15. Clouse, K. A. et al. Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. J Immunol 142, 431-438 (1989).
16. Duh, E. J., Maury, W. J., Folks, T. M., Fauci, A. S. & Rabson, A. B. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proceedings of the National Academy of Sciences of the United States of America 86, 5974-5978 (1989).
17. Braud, V. M., Allan, D. S., Wilson, D. & McMichael, A. J. TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr Biol 8, 1-10 (1998).
18. Setini, A. et al. Distinctive features of the alpha 1-domain alpha helix of HLA-C heavy chains free of beta 2-microglobulin. Hum Immunol 46, 69-81 (1996).
19. Hallermalm, K. et al. Tumor necrosis factor-alpha induces coordinated changes in major histocompatibility class I presentation pathway, resulting in increased stability of class I complexes at the cell surface. Blood 98, 1108-1115 (2001).
20. Kerppola, T. K. Bimolecular fluorescence complementation: visualization of molecular interactions in living cells. Methods Cell Biol 85, 431-470 (2008).
21. Hu, C. D. & Kerppola, T. K. Simultaneous visualization of multiple protein interactions in living cells using multicolor fluorescence complementation analysis. Nat Biotechnol 21, 539-545 (2003).
22. Chida, K., Nagamori, S. & Kuroki, T. Nuclear translocation of Fos is stimulated by interaction with Jun through the leucine zipper. Cell Mol Life Sci 55, 297-302 (1999).
23. Center, R. J. et al. Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface. J Virol 76, 7863-7867 (2002).
24. Lomant, A. J. & Fairbanks, G. Chemical probes of extended biological structures: synthesis and properties of the cleavable protein cross-linking reagent [35S]dithiobis(succinimidyl propionate). Journal of molecular biology 104, 243-261 (1976).
25. Jones, D. H., McBride, B. W., Roff, M. A. & Farrar, G. H. Efficient purification and rigorous characterisation of a recombinant gp120 for HIV vaccine studies. Vaccine 13, 991-999 (1995).
26. Ryan, S. O. & Cobb, B. A. Host glycans and antigen presentation. Microbes and infection/Institut Pasteur 14, 894-903 (2012).
27. Li, M. et al. Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J Virol 79, 10108-10125 (2005).
28. Sibilio, L. et al. A single bottleneck in HLA-C assembly. J Biol Chem 283, 1267-1274 (2008).
29. Arosa, F. A., Santos, S. G. & Powis, S. J. Open conformers: the hidden face of MHC-I molecules. Trends Immunol 28, 115-123 (2007).
30. Ott, D. E. Cellular proteins detected in HIV-1. Rev Med Virol 18, 159-175 (2008).
31. Tremblay, M. J., Fortin, J. F. & Cantin, R. The acquisition of host-encoded proteins by nascent HIV-1. Immunol Today 19, 346-351 (1998).
32. Corrah, T. W. et al. Reappraisal of the relationship between the HIV-1-protective single-nucleotide polymorphism 35 kilobases upstream of the HLA-C gene and surface HLA-C expression. Journal of virology 85, 3367-3374 (2011).
33. Fellay, J. et al. A whole-genome association study of major determinants for host control of HIV-1. Science 317, 944-947 (2007).
34. Apps, R. et al. Influence of HLA-C expression level on HIV control. Science 340, 87-91 (2013).
35. Colonna, M., Borsellino, G., Falco, M., Ferrara, G. B. & Strominger, J. L. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proceedings of the National Academy of Sciences of the United States of America 90, 12000-12004 (1993).
36. Lo Monaco, E. et al. Comment on "Influence of HLA-C expression level on HIV control". Science 341, 1175 (2013).
37. Shields, M. J., Hodgson, W. & Ribaudo, R. K. Differential association of beta2-microglobulin mutants with MHC class I heavy chains and structural analysis demonstrate allele-specific interactions. Mol Immunol 36, 561-573 (1999).
38. Grundy, J. E., McKeating, J. A., Ward, P. J., Sanderson, A. R. & Griffiths, P. D. Beta 2 microglobulin enhances the infectivity of cytomegalovirus and when bound to the virus enables class I HLA molecules to be used as a virus receptor. J Gen Virol 68(Pt 3), 793-803 (1987).
39. Capobianchi, M. R. et al. A simple and reliable method to detect cell membrane proteins on infectious human immunodeficiency virus type 1 particles. J Infect Dis 169, 886-889 (1994).
40. Timar, J., Nagy, K., Robertson, D., Clapham, P. & Weiss, R. A. Ultrastructure and immunoelectron microscopy of human T-cell leukaemia virus type I-producing lymphoid and non-lymphoid human tumour cells. J Gen Virol 68(Pt 4), 1011-1020 (1987).
41. Ward, J. P., Bonaparte, M. I. & Barker, E. HLA-C and HLA-E reduce antibody-dependent natural killer cell-mediated cytotoxicity of HIV-infected primary T cell blasts. AIDS 18, 1769-1779 (2004).
42. Triantafilou, M. et al. Involvement of beta2-microglobulin and integrin alphavbeta3 molecules in the coxsackievirus A9 infectious cycle. J Gen Virol 80(Pt 10), 2591-2600 (1999).
43. Bremnaes, C. & Meyer, D. The HIV-based host derived R7V epitope; functionality of antibodies directed at it and the predicted implications for prognosis, therapy or vaccine development. Biotechnol. Mol. Biol. Rev. 3, 71-80 (2009).
44. Schwartz, O., Alizon, M., Heard, J. M. & Danos, O. Impairment of T cell receptor-dependent stimulation in CD4+ lymphocytes after contact with membrane-bound HIV-1 envelope glycoprotein. Virology 198, 360-365 (1994).
45. Platt, E. J., Wehrly, K., Kuhmann, S. E., Chesebro, B. & Kabat, D. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J Virol 72, 2855-2864 (1998).
46. Folks, T. et al. Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus. Proceedings of the National Academy of Sciences of the United States of America 82, 4539-4543 (1985).
47. Biswas, P. et al. Cross-linking of CD30 induces HIV expression in chronically infected T cells. Immunity 2, 587-596 (1995).
48. Poli, G. et al. Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proceedings of the National Academy of Sciences of the United States of America 87, 782-785 (1990).
49. Arya, S. K., Guo, C., Josephs, S. F. & Wong-Staal, F. Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). Science 229, 69-73 (1985).
50. Wei, X. et al. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother 46, 1896-1905 (2002).
51. Nguyen, K. L. et al. Codon optimization of the HIV-1 vpu and vif genes stabilizes their mRNA and allows for highly efficient Revindependent expression. Virology 319, 163-175 (2004).
52. Schwartz, S. et al. Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Revindependent gag expression. J Virol 66, 7176-7182 (1992).
53. Zipeto, D. et al. Induction of human immunodeficiency virus neutralizing antibodies using fusion complexes. Microbes and infection/Institut Pasteur 8, 1424-1433 (2006).
54. Pizzato, M. et al. Dynamin 2 is required for the enhancement of HIV-1 infectivity by Nef. Proceedings of the National Academy of Sciences of the United States of America 104, 6812-6817 (2007).
55. Mandal, P. K. et al. Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9. Cell Stem Cell 15, 643-652 (2014).
56. Buchacher, A. et al. Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization. AIDS research and human retroviruses 10, 359-369 (1994).
57. Parham, P., Barnstable, C. J. & Bodmer, W. F. Use of a monoclonal antibody (W6/32) in structural studies of HLA-A, B, C, antigens. J Immunol 123, 342-349 (1979).
58. Pellegrino, M. A., Ng, A. K., Russo, C. & Ferrone, S. Heterogeneous distribution of the determinants defined by monoclonal antibodies on HLA-A and B antigens bearing molecules. Transplantation 34, 18-23 (1982).
59. Gilljam, G. Envelope glycoproteins of HIV-1, HIV-2, and SIV purified with Galanthus nivalis agglutinin induce strong immune responses. AIDS research and human retroviruses 9, 431-438 (1993).
60. Serena, M. et al. Molecular characterization of HIV-1 Nef and ACOT8 interaction: insights from in silico structural predictions and in vitro functional assays. Sci Rep 6, 22319 (2016).